Last reviewed · How we verify

Pain Relief Ointment

Johnson & Johnson Consumer and Personal Products Worldwide · FDA-approved active Small molecule

Pain Relief Ointment provides topical analgesia by delivering active ingredients through the skin to reduce localized pain and inflammation.

Pain Relief Ointment provides topical analgesia by delivering active ingredients through the skin to reduce localized pain and inflammation. Used for Localized musculoskeletal pain and minor aches, Arthritis pain relief.

At a glance

Generic namePain Relief Ointment
Also known asNeosporin® Plus Pain relief Ointment
SponsorJohnson & Johnson Consumer and Personal Products Worldwide
Drug classTopical analgesic
ModalitySmall molecule
Therapeutic areaPain Management
PhaseFDA-approved

Mechanism of action

Topical pain relief ointments typically contain analgesic and/or anti-inflammatory agents (such as menthol, camphor, salicylates, or NSAIDs) that penetrate the skin to desensitize nerve endings and reduce inflammatory mediators in the affected tissue. The exact active ingredients and their concentrations determine the specific mechanism, but the general approach is local delivery to avoid systemic exposure while providing targeted pain relief.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: